US4349552A
(en)
|
1978-10-30 |
1982-09-14 |
Fujisawa Pharmaceutical Company, Ltd. |
5-Fluorouracil derivatives, and their pharmaceutical compositions
|
PT85662B
(pt)
|
1986-09-10 |
1990-06-29 |
Sandoz Sa |
Processo para a preparacao de derivados de aza-indol e de indolizina e de composicoes farmaceuticas que os contem
|
MX19185A
(es)
|
1989-01-20 |
1993-12-01 |
Pfizer |
Procedimiento para preparar 3-(1,2,5,6-tretrahidropiridil)-pirrolopiridinas.
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
FR2687402B1
(fr)
|
1992-02-14 |
1995-06-30 |
Lipha |
Nouveaux azaindoles, procedes de preparation et medicaments les contenant.
|
DE4304455A1
(de)
|
1993-02-15 |
1994-08-18 |
Bayer Ag |
Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate
|
US5716981A
(en)
|
1993-07-19 |
1998-02-10 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic compositions and methods of use
|
IL129871A
(en)
*
|
1994-05-06 |
2003-11-23 |
Pharmacia & Upjohn Inc |
Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
|
US6075037A
(en)
|
1994-06-09 |
2000-06-13 |
Smithkline Beecham Corporation |
Endothelin receptor antagonists
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
GB9721437D0
(en)
|
1997-10-10 |
1997-12-10 |
Glaxo Group Ltd |
Heteroaromatic compounds and their use in medicine
|
ATE269303T1
(de)
|
1999-01-07 |
2004-07-15 |
Wyeth Corp |
Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
|
US6313126B1
(en)
|
1999-01-07 |
2001-11-06 |
American Home Products Corp |
Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
|
AU2494300A
(en)
|
1999-01-07 |
2000-07-24 |
American Home Products Corporation |
3,4-dihydro-2h-benzo(1,4)oxazine derivatives
|
US6265403B1
(en)
|
1999-01-20 |
2001-07-24 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
AR028475A1
(es)
|
1999-04-22 |
2003-05-14 |
Wyeth Corp |
Derivados de azaindol y uso de los mismos para la manufactura de un medicamento para el tratamiento de la depresion.
|
US20030153560A1
(en)
|
1999-04-23 |
2003-08-14 |
Salituro Francesco G. |
Inhibitors of c-Jun N-terminal kinases (JNK)
|
WO2001001986A1
(en)
|
1999-07-02 |
2001-01-11 |
Lipton Stuart A |
Method of reducing neuronal injury or apoptosis
|
GB9919843D0
(en)
|
1999-08-20 |
1999-10-27 |
Smithkline Beecham Plc |
Novel compounds
|
DE19948417A1
(de)
|
1999-10-07 |
2001-04-19 |
Morphochem Ag |
Imidazol-Derivate und ihre Verwendung als Arzneimittel
|
US20020065270A1
(en)
|
1999-12-28 |
2002-05-30 |
Moriarty Kevin Joseph |
N-heterocyclic inhibitors of TNF-alpha expression
|
JP2003519143A
(ja)
|
1999-12-28 |
2003-06-17 |
ファーマコピーア,インコーポレーティッド |
ピリミジン及びトリアジン系キナーゼ阻害剤
|
CN1429222A
(zh)
|
2000-02-17 |
2003-07-09 |
安姆根有限公司 |
激酶抑制剂
|
US7041277B2
(en)
|
2000-03-10 |
2006-05-09 |
Cadbury Adams Usa Llc |
Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same
|
CA2308994A1
(en)
|
2000-05-19 |
2001-11-19 |
Aegera Therapeutics Inc. |
Neuroprotective compounds
|
US6635633B2
(en)
|
2000-08-14 |
2003-10-21 |
Ortho-Pharmaceutical, Inc. |
Substituted pyrazoles
|
WO2002020002A2
(en)
|
2000-09-06 |
2002-03-14 |
Ortho Mcneil Pharmaceutical, Inc. |
A method for treating allergies
|
DK1315492T3
(da)
|
2000-09-06 |
2008-10-13 |
Ortho Mcneil Pharm Inc |
Anvendelse af substituerede pyrazoler til behandling af allergier
|
UY26942A1
(es)
|
2000-09-20 |
2002-04-26 |
Abbott Lab |
N-acilsulfonamidas promotoras de la apoptosis
|
HUP0400684A2
(hu)
|
2000-12-22 |
2004-07-28 |
Wyeth |
5-Hidroxitriptamin-6-ligandumként használható heterociklilindazol- és -azaindazol-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
|
WO2002070662A2
(en)
|
2001-03-02 |
2002-09-12 |
Gpc Biotech Ag |
Three hybrid assay system
|
WO2002072587A1
(en)
|
2001-03-14 |
2002-09-19 |
Wyeth |
Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline
|
US7081454B2
(en)
|
2001-03-28 |
2006-07-25 |
Bristol-Myers Squibb Co. |
Tyrosine kinase inhibitors
|
EP1381600A1
(en)
|
2001-04-24 |
2004-01-21 |
Wyeth, A Corporation of the State of Delaware |
Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
|
US6656950B2
(en)
|
2001-04-25 |
2003-12-02 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
|
ATE279415T1
(de)
|
2001-04-26 |
2004-10-15 |
Wyeth Corp |
Antidepressiv wirksame azaheterocyclymethyl- derivative von oxaheterocycyl-anellierten (1,4)- benzodioxanen
|
US6593350B2
(en)
|
2001-04-26 |
2003-07-15 |
Wyeth |
Antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7H-[1,4]dioxino[2,3-e]indole
|
DE60206048T2
(de)
|
2001-04-26 |
2006-07-13 |
Wyeth |
Antidepressive (sssri) azaheterocyclylmethylderivate von 7,8-dihydro-3h-6,9-dioxa-1,3-diazacyclopenta [a] naphthalin
|
WO2002088129A1
(en)
|
2001-04-26 |
2002-11-07 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
|
CA2445581A1
(en)
|
2001-04-26 |
2002-11-07 |
Jonathan Laird Gross |
Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoxaline
|
US6555560B2
(en)
|
2001-04-30 |
2003-04-29 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
|
US6525075B2
(en)
|
2001-04-30 |
2003-02-25 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
|
GB0111186D0
(en)
|
2001-05-08 |
2001-06-27 |
Smithkline Beecham Plc |
Novel compounds
|
CA2447150A1
(en)
|
2001-05-17 |
2002-11-21 |
Wyeth |
Processes for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline
|
ATE432929T1
(de)
|
2001-06-15 |
2009-06-15 |
Vertex Pharma |
5-(2-aminopyrimidin-4-yl)benzisoxazole als proteinkinasehemmer
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
WO2003010169A1
(en)
|
2001-07-25 |
2003-02-06 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 7, 8-dihydro-6h-5-oxa-1-aza-phenanthrene
|
JP4370164B2
(ja)
|
2001-08-14 |
2009-11-25 |
富山化学工業株式会社 |
新規なウイルス増殖阻害・殺ウイルス方法および新規なピラジンヌクレオチド・ピラジンヌクレオシド類似体
|
US20040236110A1
(en)
|
2001-09-26 |
2004-11-25 |
Ladouceur Gaetan H |
Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
|
US6667322B2
(en)
|
2001-10-05 |
2003-12-23 |
Wyeth |
Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole
|
US7361671B2
(en)
|
2001-11-15 |
2008-04-22 |
The Institute For Pharmaceutical Discovery, Inc. |
Substituted heteroarylalkanoic acids
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
AU2003216660A1
(en)
|
2002-04-26 |
2003-11-10 |
Pfizer Products Inc. |
N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
|
AU2003237121A1
(en)
|
2002-04-26 |
2003-11-10 |
Vertex Pharmaceuticals Incorporated |
Pyrrole derivatives as inhibitors of erk2 and uses thereof
|
EP1510516A4
(en)
|
2002-05-31 |
2005-11-02 |
Eisai Co Ltd |
PYRAZOL COMPOUND AND MEDICAL COMPOSITION CONTAINING THEM
|
UA78999C2
(en)
|
2002-06-04 |
2007-05-10 |
Wyeth Corp |
1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
|
PL374967A1
(en)
|
2002-08-02 |
2005-11-14 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compositions useful as inhibitors of gsk-3
|
WO2004014912A1
(en)
|
2002-08-08 |
2004-02-19 |
Ribapharm Inc. |
Improved synthesis for hydroxyalkylated heterocyclic bases
|
SE0202463D0
(sv)
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
Novel compounds
|
WO2004037814A1
(en)
|
2002-10-25 |
2004-05-06 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
PT1599478E
(pt)
|
2003-02-26 |
2007-05-31 |
Boehringer Ingelheim Pharma |
Di-hidropteridinonas, proceso para a sua preparação e a sua utilização como medicamento
|
EP2295433A3
(en)
|
2003-03-06 |
2011-07-06 |
Eisai R&D Management Co., Ltd. |
JNK inhibitors
|
US7375228B2
(en)
|
2003-03-17 |
2008-05-20 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
GB0308466D0
(en)
|
2003-04-11 |
2003-05-21 |
Novartis Ag |
Organic compounds
|
WO2004106298A1
(en)
|
2003-05-30 |
2004-12-09 |
Janssen Pharmaceutica N.V. |
Indole derivatives with an improved antipsychotic activity
|
WO2005000813A1
(en)
|
2003-05-30 |
2005-01-06 |
Imclone Systems Incorporated |
Heteroarylamino-phenylketone derivatives and their use as kinase inhibitors
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
WO2005044181A2
(en)
|
2003-09-09 |
2005-05-19 |
Temple University-Of The Commonwealth System Of Higher Education |
Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors
|
JP2007507529A
(ja)
|
2003-09-30 |
2007-03-29 |
サイオス・インコーポレーテツド |
複素環式アミドおよびスルホンアミド
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
WO2005062795A2
(en)
|
2003-12-19 |
2005-07-14 |
Plexxikon, Inc. |
Compounds and methods for development of ret modulators
|
US20070066641A1
(en)
|
2003-12-19 |
2007-03-22 |
Prabha Ibrahim |
Compounds and methods for development of RET modulators
|
GB0405055D0
(en)
|
2004-03-05 |
2004-04-07 |
Eisai London Res Lab Ltd |
JNK inhibitors
|
RU2403252C2
(ru)
|
2004-03-30 |
2010-11-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Азаиндолы, полезные в качестве ингибиторов jak и других протеинкиназ
|
CA2561724A1
(en)
|
2004-04-02 |
2005-11-03 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of rock and other protein kinases
|
ITMI20040874A1
(it)
|
2004-04-30 |
2004-07-30 |
Ist Naz Stud Cura Dei Tumori |
Derivati indolici ed azaindolici con azione antitumorale
|
KR100476851B1
(ko)
|
2004-05-18 |
2005-03-17 |
(주)성신엔지니어링 |
중력식 섬유여과기
|
WO2006009755A2
(en)
|
2004-06-17 |
2006-01-26 |
Plexxikon, Inc. |
Azaindoles modulating c-kit activity and uses therefor
|
DE102004029784A1
(de)
|
2004-06-21 |
2006-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
|
US7173031B2
(en)
|
2004-06-28 |
2007-02-06 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
US20060122213A1
(en)
|
2004-06-30 |
2006-06-08 |
Francoise Pierard |
Azaindoles useful as inhibitors of protein kinases
|
MX2007001127A
(es)
|
2004-07-27 |
2007-07-11 |
Sgx Pharmaceuticals Inc |
Moduladores de pirrolo-piridina cinasa.
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
CA2582235A1
(en)
|
2004-10-04 |
2006-04-20 |
Millennium Pharmaceuticals, Inc. |
Lactam compounds useful as protein kinase inhibitors
|
WO2006038001A1
(en)
|
2004-10-06 |
2006-04-13 |
Celltech R & D Limited |
Aminopyrimidine derivatives as jnk inhibitors
|
US7855205B2
(en)
|
2004-10-29 |
2010-12-21 |
Janssen Pharmaceutica Nv |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
DK1812440T3
(da)
|
2004-11-04 |
2011-01-31 |
Vertex Pharma |
Pyrazolo[1,5-a]pyrimidiner, der kan anvendes som inhibistorer af proteinkinaser
|
US20060122185A1
(en)
|
2004-11-22 |
2006-06-08 |
Jeremy Green |
Bicyclic inhibitors of Rho kinase
|
EP1828180A4
(en)
|
2004-12-08 |
2010-09-15 |
Glaxosmithkline Llc |
1H-pyrrolo [2,3-BETA] PYRIDINE
|
US8101770B2
(en)
|
2004-12-16 |
2012-01-24 |
Vertex Pharmaceuticals Incorporated |
Pyridones useful as inhibitors of kinases
|
US20060161001A1
(en)
|
2004-12-20 |
2006-07-20 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
AU2006221065A1
(en)
|
2005-02-03 |
2006-09-14 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyrimidines useful as inhibitors of protein kinase
|
CA2608333A1
(en)
|
2005-05-16 |
2006-11-23 |
Irm Llc |
Pyrrolopyridine derivatives as protein kinase inhibitors
|
EP1881983B1
(en)
|
2005-05-20 |
2012-01-11 |
Vertex Pharmaceuticals, Inc. |
Pyrrolopyridines useful as inhibitors of protein kinase
|
EP1893612B1
(en)
|
2005-06-22 |
2011-08-03 |
Plexxikon, Inc. |
Pyrrolo [2, 3-b]pyridine derivatives as protein kinase inhibitors
|
GB0516156D0
(en)
|
2005-08-05 |
2005-09-14 |
Eisai London Res Lab Ltd |
JNK inhibitors
|
KR20080063809A
(ko)
|
2005-09-30 |
2008-07-07 |
버텍스 파마슈티칼스 인코포레이티드 |
야누스 키나아제의 억제제로서 유용한 데아자퓨린
|
WO2007059219A1
(en)
|
2005-11-15 |
2007-05-24 |
Vertex Pharmaceuticals Incorporated |
Azaindazoles useful as inhibitors of kinases
|
US20130096302A1
(en)
|
2005-11-22 |
2013-04-18 |
Hayley Binch |
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
|
EP2537849A3
(en)
*
|
2006-01-17 |
2013-04-03 |
Vertex Pharmaceuticals, Inc. |
Azaindoles useful as inhibitors of janus kinases
|
AU2007215221C1
(en)
|
2006-02-14 |
2013-05-30 |
Vertex Pharmaceuticals Incorporated |
Dihydrodiazepines useful as inhibitors of protein kinases
|
AU2007215161A1
(en)
|
2006-02-14 |
2007-08-23 |
Vertex Pharmaceuticals Incorporated |
Pyrrolo(3,2-C) pyridines useful as inhibitors of protein kinases
|
DE102006012617A1
(de)
|
2006-03-20 |
2007-09-27 |
Merck Patent Gmbh |
4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate
|
JP2009532475A
(ja)
|
2006-04-05 |
2009-09-10 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ヤヌスキナーゼの阻害剤として有用なデアザプリン
|
EP2032582A1
(en)
|
2006-04-26 |
2009-03-11 |
F.Hoffmann-La Roche Ag |
Pyrimidine derivatives as pi3k inhibitors
|
WO2007129195A2
(en)
|
2006-05-04 |
2007-11-15 |
Pfizer Products Inc. |
4-pyrimidine-5-amino-pyrazole compounds
|
US20090017444A1
(en)
|
2006-06-09 |
2009-01-15 |
Wisconsin Alumni Research Foundation |
Screening method for modulators of viral transcription or replication
|
ES2431466T3
(es)
|
2006-06-30 |
2013-11-26 |
Sunesis Pharmaceuticals, Inc. |
Inhibidores de piridinonil pdk1
|
TW200808325A
(en)
|
2006-07-06 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds
|
US8022205B2
(en)
|
2006-08-08 |
2011-09-20 |
Chugai Seiyaku Kabushiki Kaisha |
Pyrimidine derivatives as PI3K inhibitor and use thereof
|
MX2009002046A
(es)
|
2006-08-24 |
2009-03-06 |
Astrazeneca Ab |
Derivados de morfolino pirimidina utiles en el tratamiento de trastornos proliferativos.
|
US20130310418A1
(en)
|
2006-11-15 |
2013-11-21 |
Vertex Pharmaceuticals Incorporated |
Azaindazoles useful as inhibitors of kinases
|
DE602007012473D1
(de)
|
2006-12-14 |
2011-03-24 |
Vertex Pharma |
Als proteinkinaseinhibitoren geeignete verbindungen
|
CA2673472A1
(en)
|
2006-12-21 |
2008-07-03 |
Vertex Pharmaceuticals Incorporated |
5-cyan0-4- (pyrrolo) [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
|
TW200840581A
(en)
|
2007-02-28 |
2008-10-16 |
Astrazeneca Ab |
Novel pyrimidine derivatives
|
JP2010520887A
(ja)
|
2007-03-09 |
2010-06-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
蛋白キナーゼの阻害剤として有用なアミノピリジン
|
EP2137183B1
(en)
|
2007-03-09 |
2011-09-28 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
CN101663295B
(zh)
|
2007-03-09 |
2014-11-05 |
沃泰克斯药物股份有限公司 |
可用作蛋白激酶抑制剂的氨基嘧啶类化合物
|
MX2009010034A
(es)
|
2007-03-22 |
2009-10-12 |
Hoffmann La Roche |
Pirimidodiazepinas sustituidas utiles inhibidores de la plk1.
|
RU2339637C1
(ru)
|
2007-04-05 |
2008-11-27 |
Андрей Александрович Иващенко |
Блокаторы гистаминного рецептора для фармацевтических композиций, обладающих противоаллергическим и аутоиммунным действием
|
RU2334747C1
(ru)
|
2007-04-05 |
2008-09-27 |
Андрей Александрович Иващенко |
ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
|
CN101790532B
(zh)
|
2007-07-31 |
2013-11-20 |
沃泰克斯药物股份有限公司 |
5-氟-1H-吡唑并[3,4-b]吡啶-3-胺及其衍生物的制备方法
|
WO2009023269A2
(en)
|
2007-08-15 |
2009-02-19 |
Vertex Pharmaceuticals Incorporated |
4-(9-(3, 3-difluorocyclopentyl) -5, 7, 7-trimethyl-6-oxo-6, 7, 8, 9-tetrahydro-5h-pyrimido [4, 5-b[1, 4] diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases plk1 to plk4 for the treatment of proliferative diseases
|
PL2205603T3
(pl)
|
2007-09-28 |
2014-07-31 |
Cyclacel Ltd |
Pochodne pirymidyny jako inhibitory kinaz białkowych
|
JP5725861B2
(ja)
|
2007-10-09 |
2015-05-27 |
ヨーロピアン モレキュラー バイオロジー ラボラトリー |
可溶性rnaキャップ結合ポケット断片、及びその使用
|
EP2215089B1
(en)
|
2007-11-02 |
2012-06-27 |
Vertex Pharmaceuticals Incorporated |
[1h- pyrazolo [3, 4-b]pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
|
WO2009059943A1
(en)
|
2007-11-05 |
2009-05-14 |
Novartis Ag |
4-benzylamino-1-carboxyacyl-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
|
AU2009218607B2
(en)
|
2008-02-25 |
2014-02-13 |
F. Hoffmann-La Roche Ag |
Pyrrolopyrazine kinase inhibitors
|
JP2011513483A
(ja)
|
2008-03-10 |
2011-04-28 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
タンパク質キナーゼの阻害剤として有用なピリミジンおよびピリジン
|
US20110033473A1
(en)
|
2008-04-09 |
2011-02-10 |
Yoram Reiter |
Anti influenza antibodies and uses thereof
|
NZ590266A
(en)
|
2008-06-23 |
2012-08-31 |
Vertex Pharma |
Protein kinase inhibitors based on dihydro-5h-pyrimido[4,5-b]diazepin or dihydropteridin
|
MX2011000021A
(es)
|
2008-06-23 |
2011-02-24 |
Vertex Pharma |
Inhibidores de proteina cinasas.
|
AU2009274027A1
(en)
|
2008-07-23 |
2010-01-28 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
WO2010011768A1
(en)
|
2008-07-23 |
2010-01-28 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
CA2731451A1
(en)
|
2008-07-23 |
2010-01-28 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridine kinase inhibitors
|
US8569337B2
(en)
|
2008-07-23 |
2013-10-29 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
WO2010011762A1
(en)
|
2008-07-23 |
2010-01-28 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridine kinase inhibitors
|
EP2427464A1
(en)
|
2009-05-06 |
2012-03-14 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridines
|
EP3141252B8
(en)
|
2009-06-17 |
2019-03-13 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
WO2011000566A2
(en)
|
2009-06-30 |
2011-01-06 |
Savira Pharmaceuticals Gmbh |
Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections
|
EP2454257B1
(en)
|
2009-07-15 |
2013-08-21 |
AbbVie Inc. |
Pyrrolopyridine inhibitors of kinases
|
JP5685895B2
(ja)
*
|
2009-12-11 |
2015-03-18 |
株式会社リコー |
画像処理装置、画像処理方法およびプログラム
|
CN102933206A
(zh)
|
2010-04-07 |
2013-02-13 |
弗特克斯药品有限公司 |
3-(6-(1-(2,2-二氟苯并[d][1,3]二氧杂环戊烯-5-基)环丙烷甲酰胺基)-3-甲基吡啶-2-基)苯甲酸的固体形式
|
WO2011130146A1
(en)
|
2010-04-14 |
2011-10-20 |
Array Biopharma Inc. |
5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of jak kinases
|
EP2563125A4
(en)
|
2010-04-27 |
2013-10-02 |
Merck Sharp & Dohme |
AZAINDOLE AS JANUSKINASE HEMMER
|
MX2013006846A
(es)
|
2010-12-16 |
2013-12-16 |
Vertex Pharma |
Inhibidores de la replicacion de los virus de la influenza.
|
AU2011343647A1
(en)
|
2010-12-16 |
2013-05-02 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
CN103492381A
(zh)
|
2010-12-16 |
2014-01-01 |
沃泰克斯药物股份有限公司 |
流感病毒复制的抑制剂
|
EP2729465A2
(en)
|
2011-07-05 |
2014-05-14 |
Vertex Pharmaceuticals Incorporated |
Processes and intermediates for producing azaindoles
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
AU2012336019A1
(en)
|
2011-11-07 |
2014-05-29 |
Vertex Pharmaceuticals Incorporated |
Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor
|
WO2013184985A1
(en)
|
2012-06-08 |
2013-12-12 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
WO2015038655A1
(en)
|
2013-09-12 |
2015-03-19 |
Alios Biopharma, Inc. |
Aza-pyridone compounds and uses thereof
|
US9296727B2
(en)
|
2013-10-07 |
2016-03-29 |
Vertex Pharmaceuticals Incorporated |
Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
|
AU2014348840B2
(en)
|
2013-11-13 |
2019-06-06 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
EP3851437A3
(en)
|
2013-11-13 |
2021-11-03 |
Vertex Pharmaceuticals Incorporated |
Methods of preparing 1h-pyrrolo[2,3-b]pyridine derivates
|
CN105848683A
(zh)
|
2013-11-13 |
2016-08-10 |
沃泰克斯药物股份有限公司 |
氮杂吲哚化合物的制剂
|
MX2017001752A
(es)
|
2014-08-08 |
2018-02-08 |
Janssen Sciences Ireland Uc |
Indoles para su uso en la infección por el virus de la gripe.
|
EP3191489B1
(en)
|
2014-09-08 |
2021-01-06 |
Janssen Sciences Ireland Unlimited Company |
Pyrrolopyrimidines for use in influenza virus infection
|
MA40772A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus de la grippe a
|
MA40773A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus influenza a
|
WO2016183116A1
(en)
|
2015-05-13 |
2016-11-17 |
Vertex Pharmaceuticals Incorporated |
Methods of preparing inhibitors of influenza viruses replication
|
WO2016183120A1
(en)
|
2015-05-13 |
2016-11-17 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
US10626108B2
(en)
|
2015-11-27 |
2020-04-21 |
Janssen Sciences Ireland Uc |
Heterocyclic indoles for use in influenza virus infection
|
DK3400225T3
(da)
|
2016-01-07 |
2022-01-03 |
Janssen Sciences Ireland Unlimited Co |
Pentansyrederivater substitueret med pyrrolo-[2,3-b]pyrimidinpyridiner til behandling af influenzavirusinfektioner
|
EP3405466B1
(en)
|
2016-01-20 |
2020-11-18 |
Janssen Sciences Ireland Unlimited Company |
Aryl substituted pyrimidines for use in influenza virus infection
|
WO2017223231A1
(en)
|
2016-06-21 |
2017-12-28 |
Alios Biopharma, Inc. |
(s)-8-(benzhydryl )-6-isopropyl-3,5-dioxo- 5, 6,7,8,-tetrahydro-3h-pyrazino-[1,2-b]pyridazin-yl-isobutyrate antiviral agent for use in treating influenza
|
EP3609502A1
(en)
|
2017-04-12 |
2020-02-19 |
Vertex Pharmaceuticals Incorporated |
Combination therapies for treating influenza virus infection
|